Claes Wahlestedt
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Claes Wahlestedt is a Swedish-American biomedical researcher and entrepreneur. He is a professor at the University of Miami.
Claes Wahlestedt is a Swedish-American biomedical researcher and entrepreneur. He is a professor at the University of Miami.
Research
He is the inventor of the so-called AntagoNAT oligonucleotide technology, which allows for upregulation of genes in genetic and other disorders. A number of small molecule drugs have also been discovered by or under Wahlestedt's direction.
Career
He was a founding faculty member and director of neuroscience research at the Florida campus of The Scripps Research Institute (2005-20111). In recent years he has co-founded several biotechnology companies, including CuRNA Inc., which was acquired by OPKO Health in 2011, Epigenetix Inc. and Jupiter Orphan Therapeutics.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1369946904 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Claes Wahlestedt” date of foundation (×1) · confidence 0.95 revision URL